CVS Health did a soft rollout of its new pharmacy benefit plan that bases coverage of some drugs on cost-benefit analyses by the Institute for Clinical and Economic Review, and the company is working with patient advocacy groups before promoting the plan more widely, Chief Medical Officer Troy Brennan says.
CVS addressing patient concerns about value-based drug plan
Sign up for PCMA SmartBrief
Top news for PBMs
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.